Cincinnati, Ohio
Sleep disorder clinical trials in Cincinnati, OH
24 sleep disorder studies are recruiting participants at sites in Cincinnati as of November 16, 2026, according to ClinicalTrials.gov. Sleep Study Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Cincinnati at a glance
- 24 studies are recruiting at a site in Cincinnati.
- By phase: Phase 2 (6), Phase 2/3 (4), Phase 3 (10), Phase 4 (1), No phase (1), Observational (2). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (20), university, hospital or other (4).
- By research area: Narcolepsy (13), Sleep Apnea (8), Insomnia (3).
- Most recent update to one of these records: November 13, 2026.
Insomnia studies recruiting in Cincinnati
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Patient Priority Clinical Sites LLC
- Registry record
- NCT06559306 · updated
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Observational
- Ages 0 to 20
- All sexes
- Sponsor
- Duke University
- Study site
- Cincinnati Childrens Hospital Medical Center
- Registry record
- NCT04278404 · updated
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT06568367 · updated
Source: ClinicalTrials.gov. Data processed . See every insomnia study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Sleep apnea studies recruiting in Cincinnati
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Incannex Healthcare Ltd
- Study sites
- CTI Clinical Research Center · Intrepid Research
- Registry record
- NCT07635563 · updated
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- CTI Clinical Research Center
- Registry record
- NCT07369011 · updated
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Novo Nordisk A/S
- Study site
- CTI Clinical Research Center
- Registry record
- NCT07571109 · updated
Down Syndrome Obstructive Sleep Apnea
- Phase 2
- Ages 5 to 18
- All sexes
- Sponsor
- Brigham and Women's Hospital
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT06043440 · updated
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Novo Nordisk A/S
- Study site
- CTI Clinical Research Center
- Registry record
- NCT07571005 · updated
Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics
- Phase 4
- Ages 3 to 18
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT04991389 · updated
Comparison of a Demand Oxygen Delivery
- No phase
- Ages 5 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT06609694 · updated
Pediatric Post-Approval Registry
- Observational
- Ages 18 to 21
- All sexes
- Sponsor
- Inspire Medical Systems, Inc.
- Study site
- Cincinnati Childrens Hospital
- Registry record
- NCT04457154 · updated
Source: ClinicalTrials.gov. Data processed . See every sleep apnea study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Narcolepsy studies recruiting in Cincinnati
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Harmony Biosciences Management, Inc.
- Study site
- Intrepid Research, LLC
- Registry record
- NCT07675135 · updated
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Phase 2/3
- Ages 18 to 71
- All sexes
- Sponsor
- Takeda
- Study sites
- Takeda Site 2 · Takeda Site 4
- Registry record
- NCT07646678 · updated
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Phase 2/3
- Ages 18 to 70
- All sexes
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Study site
- Cincinnati, Ohio
- Registry record
- NCT07598708 · updated
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Phase 2/3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT06767683 · updated
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Takeda
- Study site
- Takeda Site 5
- Registry record
- NCT06952699 · updated
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Study site
- Intrepid Research
- Registry record
- NCT07625280 · updated
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Phase 3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07455383 · updated
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Phase 3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07502443 · updated
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Phase 3
- Ages 18 to 70
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07540897 · updated
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Takeda
- Study site
- Takeda Site 13
- Registry record
- NCT07633301 · updated
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Study site
- Cincinnati, Ohio
- Registry record
- NCT06752668 · updated
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Centessa Pharmaceuticals (UK) Limited
- Study site
- Cincinnati, Ohio
- Registry record
- NCT07096674 · updated
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
- Phase 2/3
- Ages 16 to 70
- All sexes
- Sponsor
- Takeda
- Study sites
- CTI Research Center · Intrepid Research
- Registry record
- NCT05816382 · updated
Source: ClinicalTrials.gov. Data processed . See every narcolepsy study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Ask about studies near Cincinnati
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
34 studies recruiting across 5 cities.
Cleveland
10 studies recruiting.
Columbus
6 studies recruiting.
Dublin
6 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Sleep Study Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections